发明名称 |
METHYL/FLUORO-PYRIDINYL-METHOXY SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS AND FLUORO-PYRIMIDINYL-METHOXY SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS |
摘要 |
The present disclosure provides methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds useful in the treatment of p38 kinase mediated diseases, such as lymphoma and auto-inflammatory disease, including rheumatoid arthritis, having the structure of Formula (I):;;wherein R1, R2, R3, R4, R5 and X are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating p38 kinase mediated diseases using the compound. |
申请公布号 |
US2014364442(A1) |
申请公布日期 |
2014.12.11 |
申请号 |
US201414298610 |
申请日期 |
2014.06.06 |
申请人 |
CONFLUENCE LIFE SCIENCES, INC. |
发明人 |
Hockerman Susan L.;Monahan Joseph B.;Selness Shaun R. |
分类号 |
C07D213/69;A61K45/06;A61K31/444;C07D401/14;A61K31/506 |
主分类号 |
C07D213/69 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein:
X is CH or N;R1 is selected from the group consisting of H, C1-C6 alkyl, fluoro, chloro, bromo, cyano, or —CF3;R2 is selected from the group consisting of H, methyl, cyano, or fluoro;R3 is selected from the group consisting of: R4 is selected from the group consisting of H, methyl, OH, and O—CH3;R5 is H or C1-C3 alkyl;m is 1 or 2;n is 0 or 1;p is 1; andq is 0 or 1. |
地址 |
St. Louis MO US |